Skip to Main Content

Paper Details

Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Gynecologic Oncology
62
2018
Cancer, LNG, Levonorgestrel, Women, breast cancer, cancer, endometrial cancer, epithelial ovarian cancer, levonorgestrel, ovarian and endometrial cancer, ovarian cancer, ovarian, endometrial, and breast cancer, person, women
Author NameAffiliation
Eiliv LundUiT - The Arctic University of Norway
  • 1 - 1

Datasets